Keywords: roche, ceo, reiterates, forecasts, having, reviewed, dismal
Roche CEO reiterates 2003 forecasts
Article | 07 April 2003
Having reviewed the dismal performance for 2002, when Switzerland'sRoche made a loss of 4.03 billion Swiss francs ($2.98 billion; Marketletter March 3), chief executive ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
